Skip to main content
Zambian nurse takes mother's blood pressure
Now more than ever, the world's most pressing
health challenges know no borders.

The Institute serves as a catalyst for global collaboration,
working with partners across the University of North Carolina and around the world.

bar of institute colors

 

Leading the response to COVID-19

At the onset of the pandemic, Institute for Global Health and Infectious Diseases researchers sprang into action, advising and partnering with the NIH, WHO and others on a coordinated response. By August 2020, Institute clinicians and researchers were engaged in 52 research projects including national vaccine and treatment trials. Watch the video at left to learn more.

 

Visit COVID-19 resources page

 

Cindy Gay, MD, on leading COVID-19 vaccine trial; Ron Falk, MD, on participating

Michelle Floris-Moore, MD, MS, talks about impact of COVID-19 on African Americans 

Michael Herce, MD, MPH, MSc: ¿Por qué participar en un esayo clinico?

photo collage researchers and coronavirus

Big Tent, One Team:

How a multidisciplinary research partnership built to fight HIV, Ebola, and other infectious diseases turned its people, expertise, and experience to fight COVID-19

In his March 23, 2021 story in UNC’s The Well, writer Scott Jared takes a deep look at the history and accomplishments of the Institute and Division of Infectious Diseases, especially how Institute Director Myron Cohen and ID Chief Joe Eron have cultivated a Big Tent way of thinking in which professionals of varying expertise work in synch with each other. The Big Tent philosophy “has no silos,” Cohen says. “We’re all working together on problems, and we all work together very successfully.”

Read story

 

cover of 2018-2020 impact report

2018-2020 Impact Report:

Pandemic highlights Institute’s critical role

Our abbreviated report includes updates from the Institute’s global sites, stats on the breadth and impact of our work, and a look at the COVID-19 research that our faculty launched in the spring of 2020 in reaction to the pandemic.

Download impact report

 

Now More Than Ever, Global is Local

RESEARCH

Solving the world’s most challenging health problems.

Learn more

three people working with microscope

EDUCATION

Cultivating the next generation of global health leaders.

Learn more

nurse measures girl's height

SERVICE

Reducing the burden of disease worldwide.

Learn more

 

bar of institute colors

Latest Institute news

See more stories here

  • Hobbs and Duncan headshots

    Hobbs and Duncan win $3.9M NIAID grant to study a meningitis vaccine’s effect on gonorrhea

    The NIH’s National Institute of Allergy and Infectious Diseases has awarded UNC’s Marcia Hobbs and Alex Duncan a five-year, $3.9 million grant to study how a vaccine recently developed to prevent life-threatening infections caused by group B Neisseria meningitidis, the MenB vaccine, may also protect people from infection with Neisseria gonorrhoeae, a sexually transmitted bacterial … Continued

  • Study from DRC shows mother-infant HBV treatment, prevention feasible

    Hepatitis B virus (HBV) remains endemic throughout sub-Saharan Africa despite the widespread availability of effective childhood vaccines. In the Democratic Republic of the Congo, HBV treatment and birth-dose vaccination programs are not established. UNC School of Medicine researchers led a study to evaluate the feasibility and acceptability of HBV testing and treatment of pregnant women, … Continued

  • headshot of david margolis

    NIH awards HIV Cure Center $26.2 million over next 5 years

    The National Institutes of Health has awarded approximately $53 million in annual funding over the next five years to 10 research organizations in a continued effort to find a cure for HIV. The new awards for the Martin Delaney Collaboratories for HIV Cure Research program, initiated in 2011, further expand the initiative’s 2016 renewal from six institutions to … Continued